Incorporation and washout of n-3 polyunsaturated fatty acids after diet supplementation in clinical studies

Journal of Cardiovascular Medicine

Volumn 8, Issue SUPPL. 1, 2007, Pages

  Masson, Serge ^a   Latini, Roberto ^b   Tacconi, Mariateresa ^b   Bernasconi, Roberto ^c  

^a NEW YORK MEDICAL COLLEGE   (United States)

^b MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^c Istituto di Ricerche Farmacologiche 'Mario Negri' ^*

Author keywords

Fish oils; n 3 polyunsaturated fatty acids; Pharmacokinetics

Indexed keywords

DOCOSAHEXAENOIC ACID; ICOSAPENTAENOIC ACID; OMEGA 3 FATTY ACID;

CONFERENCE PAPER; DIET SUPPLEMENTATION; DIETARY INTAKE; DOSE TIME EFFECT RELATION; DRUG DOSE COMPARISON; DRUG HALF LIFE; ERYTHROCYTE MEMBRANE; HEART INFARCTION; HEART INFARCTION PREVENTION; HUMAN; PRIMARY PREVENTION; SECONDARY PREVENTION; THERAPY EFFECT; TREATMENT OUTCOME; TREATMENT RESPONSE;

BLOOD CELLS; CELL MEMBRANE; DIETARY SUPPLEMENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; FATTY ACIDS, OMEGA-3; HALF-LIFE; HUMANS; PHOSPHOLIPIDS;

EID: 34548774595     PISSN: 15582027     EISSN: None     Source Type: Journal    
DOI: 10.2459/01.JCM.0000289269.98105.65     Document Type: Conference Paper

References (24)

1. GISSI-Prevenzione Investigators. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico. Lancet 1999; 354:447-455.
2. Kris-Etherton PM, Harris WS, Appel LJ; American Heart Association, Nutrition Committee. Omega-3 fatty acids and cardiovascular disease: new recommendations from the American Heart Association. Arterioscler Thromb Vasc Biol 2003; 23:151-152.
3. De Backer G, Ambrosioni E, Borch-Johnsen K, Brotons C, Cifkova R, Dallongeville J, et al. European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical Practice. Eur Heart J 2003; 24:1601-1610.
4. Siscovick DS, Raghunathan TE, King I, Weinmann S, Wicklund KG, Albright J, et al. Dietary intake and cell membrane levels of long-chain n-3 polyunsaturated fatty acids and the risk of primary cardiac arrest. JAMA 1995; 274:1363-1367.
5. Albert CM, Campos H, Stampfer MJ, Ridker PM, Manson JE, Willett WC, et al. Blood levels of long-chain n-3 fatty acids and the risk of sudden death. N Engl J Med 2002; 346:1113-1118.
6. Mori TA, Woodman RJ. The independent effects of eicosapentaenoic acid and docosahexaenoic acid on cardiovascular risk factors in humans. Curr Opin Clin Nutr Metab Care 2006; 9:95-104.
7. Harris WS, Sands SA, Windsor SL, Ali HA, Stevens TL, Magalski A, et al. Omega-3 fatty acids in cardiac biopsies from heart transplantation patients: correlation with erythrocytes and response to supplementation. Circulation 2004; 110:1645-1649.
8. Di Stasi D, Bernasconi R, Marchioli R, Marfisi RM, Rossi G, Tognoni G, et al. Early modifications of fatty acid composition in plasma phospholipids, platelets and mononucleates of healthy volunteers after low doses of n-3 polyunsaturated fatty acids. Eur J Clin Pharmacol 2004; 60:183-190.
9. Nordoy A, Barstad L, Connor WE, Hatcher L. Absorption of the n-3 eicosapentaenoic and docosahexaenoic acids as ethyl esters and triglycerides by humans. Am J Clin Nutr 1991; 53:1185-1190.
10. Cleland LG, Proudman SM, Hall C, Stamp LK, McWilliams L, Wylie N, et al. A biomarker of n-3 compliance in patients taking fish oil for rheumatoid arthritis. Lipids 2003; 38:419-424.
11. Blonk MC, Bilo HJ, Nauta JJ, Popp-Snijders C, Mulder C, Donker AJ. Dose-response effects of fish-oil supplementation in healthy volunteers. Am J Clin Nutr 1990; 52:120-127.
12. Marangoni F, Angeli MT, Colli S, Eligini S, Tremoli E, Sirtori CR, et al. Changes of n-3 and n-6 fatty acids in plasma and circulating cells of normal subjects, after prolonged administration of 20 : 5 (EPA) and 22 : 6 (DHA) ethyl esters and prolonged washout. Biochim Biophys Acta 1993; 1210:55-62.
13. Cao J, Schwichtenberg KA, Hanson NQ, Tsai MY. Incorporation and clearance of omega-3 fatty acids in erythrocyte membranes and plasma phospholipids. Clin Chem 2006; 52:2265-2272.
14. Zuijdgeest-van Leeuwen SD, Dagnelie PC, Rietveld T, van den Berg JW, Wilson JH. Incorporation and washout of orally administered n-3 fatty acid ethyl esters in different plasma lipid fractions. Br J Nutr 1999; 82:481-488.
15. Prisco D, Filippini M, Francalanci I, Paniccia R, Gensini GF, Serneri GG. Effect of n-3 fatty acid ethyl ester supplementation on fatty acid composition of the single platelet phospholipids and on platelet functions. Metabolism 1995; 44:562-569.
16. Endres S, Ghorbani R, Kelley VE, Georgilis K, Lonnemann G, van der Meer JW, et al. The effect of dietary supplementation with n-3 polyunsaturated fatty acids on the synthesis of interleukin-1 and tumor necrosis factor by mononuclear cells. N Engl J Med 1989; 320:265-271.
17. Silverman DI, Ware JA, Sacks FM, Pasternak RC. Comparison of the absorption and effect on platelet function of a single dose of n-3 fatty acids given as fish or fish oil. Am J Clin Nutr 1991; 53:1165-1170.
18. Brown AJ, Pang E, Roberts DC. Persistent changes in the fatty acid composition of erythrocyte membranes after moderate intake of n-3 polyunsaturated fatty acids: study design implications. Am J Clin Nutr 1991; 54:668-673.
19. Marsen TA, Pollok M, Oette K, Baldamus CA. Pharmacokinetics of omega-3-fatty acids during ingestion of fish oil preparations. Prostaglandins Leukot Essent Fatty Acids 1992; 46:191-196.
20. Christensen JH, Dyerberg J, Schmidt EB. n-3 Fatty acids and the risk of sudden cardiac death assessed by 24-hour heart rate variability. Lipids 1999; 34 (Suppl):S197.
21. Stark KD, Mulvad G, Pedersen HS, Park EJ, Dewailly E, Holub BJ. Fatty acid compositions of serum phospholipids of postmenopausal women: a comparison between Greenland Inuit and Canadians before and after supplementation with fish oil. Nutrition 2002; 18:627-630.
22. Mabile L, Piolot A, Boulet L, Fortin LJ, Doyle N, Rodriguez C, et al. Moderate intake of n-3 fatty acids is associated with stable erythrocyte resistance to oxidative stress in hypertriglyceridemic subjects. Am J Clin Nutr 2001; 74:449-456.
23. Mozaffarian D, Rimm EB. Fish intake, contaminants, and human health: evaluating the risks and the benefits. JAMA 2006; 296:1885-1899.
24. Leaf A, Kang JX, Xiao YF, Billman GE. Clinical prevention of sudden cardiac death by n-3 polyunsaturated fatty acids and mechanism of prevention of arrhythmias by n-3 fish oils. Circulation 2003; 107:2646-2652.